Schizophrenia

Bristol Myers Squibb acquires Karuna for $14B
By LabPulse.com staff writers
Bristol Myers Squibb has made an agreement to buy biotech firm Karuna Therapeutics for $14 billion, an acquisition that gives the firm a promising experimental treatment for schizophrenia.
December 22, 2023
Business Men Handshake Social
Genetic predisposition to smoking may drive schizophrenia heart disease risk: Study
By Nick Paul Taylor
Genetic factors are unlikely to directly drive the increased rate of cardiovascular disease in schizophrenia patients but may influence lifestyle, according to a paper in the American Journal of Psychiatry.
September 29, 2023
Cigarette Smoking Social
PixCell announces study results on HemoScreen finger-prick test
By LabPulse.com staff writers
HemoScreen, which is FDA-cleared and CE-marked, is a portable platform that offers readings of 20 standard blood count parameters within five minutes utilizing one finger-prick of blood.
December 15, 2022
Fingerprick Blood Social
Castle Biosciences completes $65M AltheaDx acquisition
By LabPulse.com staff writers
Under the terms of the definitive agreement, AltheaDx became a subsidiary of Castle Biosciences. At closing, Castle paid $65 million to AltheaDx security holders, which consisted of $32.5 million in cash and $32.5 million in Castle common stock.
April 26, 2022
2020 03 25 23 27 0591 Hands Shaking Deal 400
Blood test could identify risk of psychotic disorders
By LabPulse.com staff writers
The findings could help clinicians better assess and treat patients, wrote a team led by David Cotter, PhD, of the Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences in Dublin, Ireland.
August 27, 2020
2020 05 15 23 50 8470 2020 05 14 Bloodtest 400
Poor oral care may affect the accuracy of COVID-19 tests
By Melissa Busch
Patients who didn't brush or rinse their teeth may have allowed noninfectious viral nucleic acid to build up, resulting in prolonged viral shedding. On average, those who didn't keep their oral cavities clean continued to shed the virus for an additional two weeks and resulted in more positive real-time reverse transcription polymerase chain reaction (PCR) tests, the authors wrote.
August 3, 2020
2020 07 30 23 22 1075 Sars Co V 2 Spike Coronavirus 400
Failed study leaves CRP test hanging as biomarker in bipolar depression
By Emily Hayes
The results leave the potential role of CRP as a biomarker up in the air. They also highlight the broader challenges in developing biomarkers and personalized treatments in the field of psychiatry.
May 7, 2019
2019 05 08 23 39 6217 Lab Crp Test 400
Page 1 of 1